Barbara Ellen: They promise to reveal everything from our ancestry to our chances of serious illness. But are DNA tests accurate and do they tell us anything worthwhile?

Quick Read

On the 24th July 2017, the long-running, deeply tragic and emotionally fraught case of Charlie Gard reached its sad conclusion (Box 1). Following further medical assessment of the infant, Charlie’s parents and doctors finally reached agreement that continuing medical treatment was not in Charlie’s best interests. It is expected that life support will be withdrawn in the days ahead

Quick Read

Bringing genetics into medicine leads to more accuracy, better diagnosis and personalised treatment – but not for all. Carrie Arnold meets families for whom gene testing has led only to unanswered questions

Quick Read

Hospitals and pharmacies are required to toss expired drugs, no matter how expensive or vital. Meanwhile the FDA has long known that many remain safe and potent for years longer

Quick Read

Time to call in the ethics experts. That’s what the Wellcome Trust did in supporting the formation of the “Ethics Working Group on Zika Virus Research & Pregnancy.” Consider this a Justice League of ethics, vaccine, infectious disease, Zika, and OB/GYN experts that included Ruth Faden, PhD, MPH, Annie Lyerly, MD, MA,, and Maggie Little, BPhil, PhD, The website lists other members of the Working Group.

Quick Read

The highly anticipated court hearing comes a day after Connie Yates and Chris Gard made a public appearance to state that their son “deserves a chance” to be taken to the United States for an experimental treatment that could potentially improve his condition

Quick Read

If you were dying, surely you would grasp at any chance medicine might offer you. Recently, there has been a lot of effort at the state and federal levels to try to increase patient access to experimental drugs. The approach has been to cut the FDA out of what is known as “compassionate use”

Quick Read

Nolan and Jack Willis and just 10 other boys took part in a clinical trial that led to the approval last fall of the very first drug to treat their rare, deadly muscle disease. Now the Willis boys are again test cases as a different type of medical question comes to the fore: whether insurers will cover the controversial drug, Exondys 51, which can cost more than $1 million a year even though it’s still unclear if it works

Quick Read